Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis

Lisa M Julian; William L Stanford

doi:10.18632/oncoscience.375

Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis

Oncoscience. 2017 Nov 2;4(11-12):170-172. doi: 10.18632/oncoscience.375. eCollection 2017 Nov.

Authors

Lisa M Julian¹, William L Stanford¹

Affiliation

¹ Ottawa Hospital Research Institute, Regenerative Medicine Program, Ottawa, Ontario, Canada; University of Ottawa, Ottawa, Ontario, Canada; Ottawa Institute of Systems Biology, Ottawa, Ontario, Canada.

No abstract available

Keywords: disease cell of origin; disease modeling; lymphangioleiomyomatosis; neural crest, patient cell reprogramming; tuberous sclerosis complex.

Publication types

Editorial